Creon 60000 [USP'U]/1

Creon 60000 is a prescription medication containing pancrelipase, an enzyme replacement therapy. It is used to treat people who cannot digest food properly due to a lack of pancreatic enzymes. The medication works by replacing the enzymes normally produced by the pancreas, allowing for proper digestion and absorption of nutrients. Creon 60000 is available in a delayed-release capsule form.

Creon 60000 is commonly used to treat conditions such as cystic fibrosis, chronic pancreatitis, and pancreatic insufficiency. It is also used to treat people who have had their pancreas removed or have other conditions that affect the pancreas, such as pancreatic cancer. The medication helps to improve digestion and reduce symptoms such as bloating, gas, and diarrhea.

Common side effects of Creon 60000 include abdominal pain, diarrhea, and nausea. In rare cases, the medication can cause more serious side effects, such as allergic reactions, bowel obstruction, and increased risk of infection. Patients should be monitored closely for any signs of adverse reactions and should report any unusual symptoms to their doctor.

Creon 60000 should be stored at room temperature, away from moisture and heat. The capsules should not be crushed or chewed, as this can cause the medication to be released too quickly. Patients should follow the instructions provided by their doctor or pharmacist for taking the medication, and should not take more or less than the prescribed dose.

Creon 60000 may interact with other medications, such as antacids, blood thinners, and diabetes medications. Patients should inform their doctor about all medications they are taking, including supplements and vitamins, to minimize the risk of interactions. In addition, patients with certain medical conditions, such as gout or kidney disease, may need to use the medication with caution.